- Home
- Publications
- Publication Search
- Publication Details
Title
mRNA vaccines for cancer immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-12-14
DOI
10.3389/fimmu.2022.1029069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Research progress on dendritic cell vaccines in cancer immunotherapy
- (2022) Jifeng Yu et al. Experimental Hematology & Oncology
- Toward rational vaccine engineering
- (2022) Yashavantha L. Vishweshwaraiah et al. ADVANCED DRUG DELIVERY REVIEWS
- The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines
- (2022) Jiao Wei et al. CANCER TREATMENT REVIEWS
- Cancer vaccines as promising immuno-therapeutics: platforms and current progress
- (2022) Jian Liu et al. Journal of Hematology & Oncology
- IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines
- (2022) Siri Tahtinen et al. NATURE IMMUNOLOGY
- Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases
- (2022) Nusrat Zahan Rouf et al. RNA Biology
- mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
- (2022) Zhuoya Deng et al. Frontiers in Immunology
- The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review
- (2022) Reese Jalal Ladak et al. Frontiers in Immunology
- mRNA cancer vaccines: Advances, trends and challenges
- (2022) Qing He et al. Acta Pharmaceutica Sinica B
- Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials
- (2022) Navid Sobhani et al. CANCER TREATMENT REVIEWS
- Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion
- (2022) Zhen Qin et al. PLoS Pathogens
- mRNA vaccines: A novel weapon to control infectious diseases
- (2022) Yuying Tian et al. Frontiers in Microbiology
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- mRNA therapeutics in cancer immunotherapy
- (2021) Jan D. Beck et al. Molecular Cancer
- Cancer Vaccines, Adjuvants, and Delivery Systems
- (2021) Samantha J. Paston et al. Frontiers in Immunology
- Neoantigen: A New Breakthrough in Tumor Immunotherapy
- (2021) Zheying Zhang et al. Frontiers in Immunology
- Prophylactic Cancer Vaccines Engineered to Elicit Specific Adaptive Immune Response
- (2021) Davis W. Crews et al. Frontiers in Oncology
- Lipid Nanoparticles—From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
- (2021) Rumiana Tenchov et al. ACS Nano
- Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency
- (2021) Sun Chang Kim et al. Molecular & Cellular Toxicology
- Future considerations for the mRNA-lipid nanoparticle vaccine platform
- (2021) Botond Z Igyártó et al. Current Opinion in Virology
- Lipid nanoparticles for mRNA delivery
- (2021) Xucheng Hou et al. Nature Reviews Materials
- A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications
- (2021) Furong Qin et al. Frontiers in Cell and Developmental Biology
- To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
- (2021) Da Shi et al. ADVANCED DRUG DELIVERY REVIEWS
- Principles for designing an optimal mRNA lipid nanoparticle vaccine
- (2021) Edo Kon et al. CURRENT OPINION IN BIOTECHNOLOGY
- The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines
- (2021) P. Bigini et al. Nature Nanotechnology
- The challenge and prospect of mRNA therapeutics landscape
- (2020) Yuhua Weng et al. BIOTECHNOLOGY ADVANCES
- Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update
- (2020) Jan Dörrie et al. Pharmaceutics
- Ex vivo pulsed dendritic cell vaccination against cancer
- (2020) Yang-zhuo Gu et al. ACTA PHARMACOLOGICA SINICA
- Lipid nanoparticles for nucleic acid delivery: Current perspectives
- (2020) Eleni Samaridou et al. ADVANCED DRUG DELIVERY REVIEWS
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
- (2020) Yuanyuan Zhang et al. Cellular & Molecular Immunology
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- (2020) Ugur Sahin et al. NATURE
- Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire
- (2020) Sebastian P. Haen et al. Nature Reviews Clinical Oncology
- Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
- (2020) Maria L. Guevara et al. Frontiers in Chemistry
- Selecting Target Antigens for Cancer Vaccine Development
- (2020) Luigi Buonaguro et al. Vaccines
- The peptide vaccine of the future
- (2020) Annika Nelde et al. MOLECULAR & CELLULAR PROTEOMICS
- Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy
- (2020) Yuka Igarashi et al. Journal of Immunology Research
- A Roadmap Toward the Definition of Actionable Tumor-Specific Antigens
- (2020) Robin Minati et al. Frontiers in Immunology
- Turning the corner on therapeutic cancer vaccines
- (2019) Robert E. Hollingsworth et al. npj Vaccines
- A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge
- (2019) Elizabeth K. Duperret et al. Cancer Immunology Research
- Rationally designed carbohydrate-occluded epitopes elicit HIV-1 Env-specific antibodies
- (2019) Cheng Zhu et al. Nature Communications
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- Advances in cancer immunotherapy 2019 – latest trends
- (2019) Stephan Kruger et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Recent advances in oncolytic virus-based cancer therapy
- (2019) Luo-Qin Fu et al. VIRUS RESEARCH
- A phase 2, prospective, randomized, multicenter, open-label study of GX-188E, an HPV DNA vaccine, in patients with cervical intraepithelial neoplasia 3
- (2019) Youn Jin Choi et al. CLINICAL CANCER RESEARCH
- Delivery strategies of cancer immunotherapy: recent advances and future perspectives
- (2019) Zhongwei Zhao et al. Journal of Hematology & Oncology
- Engineering dendritic cell vaccines to improve cancer immunotherapy
- (2019) Caleb R. Perez et al. Nature Communications
- Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
- (2018) Stephen J. Russell et al. CANCER CELL
- Dendritic Cell–Based Cancer Vaccines
- (2018) Patricia M. Santos et al. JOURNAL OF IMMUNOLOGY
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Codon optimality, bias and usage in translation and mRNA decay
- (2017) Gavin Hanson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Functional 5′ UTR mRNA structures in eukaryotic translation regulation and how to find them
- (2017) Kathrin Leppek et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Tools for translation: non-viral materials for therapeutic mRNA delivery
- (2017) Khalid A. Hajj et al. Nature Reviews Materials
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer
- (2014) V. Tiriveedhi et al. CLINICAL CANCER RESEARCH
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Determinants and implications of mRNA poly(A) tail size – Does this protein make my tail look big?
- (2014) Aimee L. Jalkanen et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- A critical analysis of codon optimization in human therapeutics
- (2014) Vincent P. Mauro et al. TRENDS IN MOLECULAR MEDICINE
- A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
- (2013) S. Wilgenhof et al. ANNALS OF ONCOLOGY
- RNA: The new revolution in nucleic acid vaccines
- (2013) Andrew J. Geall et al. SEMINARS IN IMMUNOLOGY
- Challenges and advances towards the rational design of mRNA vaccines
- (2013) Charlotte Pollard et al. TRENDS IN MOLECULAR MEDICINE
- DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer
- (2013) Fredrik Eriksson et al. VACCINE
- A novel, disruptive vaccination technology
- (2013) Karl-Josef Kallen et al. Human Vaccines & Immunotherapeutics
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
- (2012) Daniel X. Johansson et al. PLoS One
- RNA-based vaccines
- (2012) Jeffrey B. Ulmer et al. VACCINE
- Rigid substructure search
- (2011) D. Shirvanyants et al. BIOINFORMATICS
- Gaia: automated quality assessment of protein structure models
- (2011) Pradeep Kota et al. BIOINFORMATICS
- Viral Vector-Based Therapeutic Cancer Vaccines
- (2011) Cecilia Larocca et al. CANCER JOURNAL
- The Present and Future of Peptide Vaccines for Cancer
- (2011) Craig L. Slingluff CANCER JOURNAL
- The Immune Response to Tumors as a Tool toward Immunotherapy
- (2011) F. Pandolfi et al. Clinical & Developmental Immunology
- The Many Pathways of RNA Degradation
- (2009) Jonathan Houseley et al. CELL
- Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines
- (2008) Tanja D. de Gruijl et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- DNA vaccines: ready for prime time?
- (2008) Michele A. Kutzler et al. NATURE REVIEWS GENETICS
- Ab Initio Folding of Proteins with All-Atom Discrete Molecular Dynamics
- (2008) Feng Ding et al. STRUCTURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now